Study to Investigate the product Wilate in Patients aged 1 to 11 years with Severe Hemophilia A
- Registry ID
- EUCTR2017-001531-40
- Source registry
- EUCTR
- Phase
- PHASE3
- Sponsor
- Octapharma AG
- Last update
- 2026-08-16
Conditions
- Severe hemophilia A (<1% FVIII:C)
Summary
The primary objective of this study is to determine the FVIII:C pharmacokinetics (PK) for Wilate in previously treated patients (PTP) with severe hemophilia A aged 1 to <12 years.
View on source registry